<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>美国首次推出阿尔茨海默氏症血液测试以用于临床 First Alzheimer's Blood Test Rolled Out for Clinical Use in US</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">First Alzheimer's Blood Test Rolled Out for Clinical Use in US<br/>美国首次推出阿尔茨海默氏症血液测试以用于临床 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2020-12-04 20:28:49</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2020/12/3bbcb337e0bff4c91594a234a211a1bb.jpg"><img src="http://img2.diglog.com/img/2020/12/3bbcb337e0bff4c91594a234a211a1bb.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>The first blood test designed to assist physicians in determining whether a patient has Alzheimer’s disease is now available in most US states, the company C 2N Diagnostics announced October 29. The test measures biomarkers that frequently reflect the presence of amyloid plaques in the brain—a hallmark of Alzheimer’s—as well as the presence of a gene variant that increases the risk of the disease.</p><p>C 2N Diagnostics公司于10月29日宣布，美国大部分州现已推出首项旨在帮助医生确定患者是否患有阿尔茨海默氏病的血液测试。该测试可检测经常反映大脑中淀粉样斑块存在的生物标志物-阿尔茨海默氏症的标志，以及存在增加该疾病风险的基因变异。</p><p> “I’m very excited about it,” says Suzanne Schindler, a neurologist at the Washington University School of Medicine in St. Louis who was involved in  testing an earlier version of the assay but is not connected to C 2N. While there are two other tests for Alzheimer’s-associated brain changes, she notes, both have logistical and financial challenges: one that collects biomarkers in the cerebrospinal fluid (CSF) requires a spinal tap, while the other, a scan called amyloid PET, involves injecting a radioactive tracer, costs thousands of dollars, and is only performed at specialized centers. “I think patients really like the idea of a blood test,” she says. “And I think that it really has the potential to allow us to do a lot more testing than we have done in the past.”</p><p> “我对此感到非常兴奋，”圣路易斯华盛顿大学医学院的神经病学家苏珊娜·辛德勒（Suzanne Schindler）说，他参与了该方法早期版本的测试，但未连接C 2N。她指出，虽然还有其他两项针对阿尔茨海默氏症相关性脑部变化的测试，但都面临着后勤和财务方面的挑战：一项在脑脊液（CSF）中收集生物标志物需要进行脊髓水龙头检查，而另一项则需要进行淀粉样蛋白PET扫描注射放射性示踪剂要花费数千美元，而且只能在专门的中心进行。她说：“我认为患者真的很喜欢验血的想法。” “而且我认为，它确实有潜力使我们比过去进行更多的测试。”</p><p> The price of the test is $1,250, says C 2N CEO Joel Braunstein, but patients who qualify for financial assistance will be charged between $25 and $400. Health insurance companies don’t currently pay for the test, he adds, but qualifying for this reimbursement “is a very high priority” for the company.</p><p> C 2N首席执行官乔尔·布劳恩斯坦（Joel Braunstein）说，测试价格为1,250美元，但有资格获得经济援助的患者将被收取25至400美元的费用。他补充说，健康保险公司目前不支付测试费用，但有资格获得此项报销“对该公司来说是非常重要的”。</p><p> “If you asked me [five or ten] years ago if there would ever be a blood test for Alzheimer’s, I would have been very skeptical,” says Howard Fillit, the executive director and chief science officer of the Alzheimer’s Drug Discovery Foundation, which invested in C 2N’s development of the test. “So the fact that this is on the market now is just amazing.”</p><p> “如果您在五到十年前问我是否要对阿尔茨海默氏症进行血液检查，我会非常怀疑，”阿尔茨海默氏症药物发现基金会执行董事兼首席科学官霍华德·菲利特（Howard Fillit）说。投资于C 2N的测试开发。 “因此，现在市场上出售的事实真是太神奇了。”</p><p> Fillit wasn’t alone in thinking that, due to the blood-brain barrier, biomarkers from the brain wouldn’t be found in peripheral blood in sufficient quantities to deliver a diagnosis. But analytical techniques have advanced in sensitivity in recent years, allowing small amounts of biomarkers in the blood to be detected.</p><p> 并非只有Fillit会认为，由于血脑屏障的缘故，在外周血中不会发现足够量的大脑生物标志物来进行诊断。但是，近年来，分析技术已经提高了灵敏度，可以检测血液中的少量生物标志物。</p><p>  The C 2N test relies on the ratio of two isoforms of the amyloid-β protein, Aβ42 and Aβ40, that aggregate to form amyloid plaques in the brain, combined with the presence of isoforms of apolipoprotein E (ApoE) that reflect whether the patient caries a genetic variant associated with Alzheimer’s risk. The results are combined into a score that indicates the probability that a patient would be found to have amyloid plaques if they were to undergo an amyloid PET scan. Doctors can then consider the test results along with other information about the patient to arrive at a diagnosis. According to data posted on the company’s  website, a study in 686 patients with cognitive impairment found that those with scores above a certain cutoff point had a positive amyloid PET scan 92 percent of the time, while those with scores below a certain cutoff had a 77 percent chance of having a negative result on the PET scan.</p><p>  C 2N测试依赖于淀粉样β蛋白的两个同工型Aβ42和Aβ40的比率，它们在大脑中聚集形成淀粉样斑块，并结合载脂蛋白E（ApoE）的同工型来反映患者是否龋齿与阿尔茨海默氏症风险相关的遗传变异。将结果组合成一个分数，该分数表明如果患者接受淀粉样蛋白PET扫描，就会发现他们患有淀粉样斑块的可能性。然后，医生可以考虑测试结果以及有关患者的其他信息，以进行诊断。根据该公司网站上发布的数据，一项针对686例认知障碍患者的研究发现，得分高于某个临界点的患者淀粉样蛋白PET扫描阳性率为92％，而得分低于某个临界点的患者则为77％。在PET扫描中出现阴性结果的机会百分比。</p><p> While no drugs have yet been approved to treat Alzheimer’s, being able to distinguish it from other possible causes of cognitive impairment is nonetheless valuable, Fillit and Schindler say. As a clinician, Schindler says, “I want to know what my patients have.” That can be complicated because in many cases, “they don’t just have memory impairment, they’re taking multiple medications, they have all sorts of health issues,” she says. “And sometimes it’s really hard to know whether the symptoms they’re experiencing are due to something like Alzheimer’s or something else.”</p><p> Fillit和Schindler说，虽然还没有批准任何药物来治疗阿尔茨海默氏症，但是能够将其与其他可能的认知障碍原因区分开仍然很有价值。作为临床医生，辛德勒说：“我想知道我的病人有什么。”她说，这可能会很复杂，因为在许多情况下，“他们不仅有记忆障碍，他们正在服用多种药物，而且还有各种各样的健康问题。” “有时候，很难知道他们所经历的症状是由于阿尔茨海默氏病还是其他原因引起的。” </p><p> Symptom-based diagnosis of Alzheimer’s disease is only about 70 percent accurate, notes Colin Masters of the Florey Institute of Neuroscience and Mental Health in Australia who was part of the team that first characterized the amyloid plaques in the disease. If a clinician suspects the disease but the blood test returns a negative result, this “will force the clinicians to go and look harder for other causes of dementia,” says Masters, who collaborates with one of the test’s developers but has no ties to C 2N. He adds that once an amyloid-targeting Alzheimer’s drug is approved, the test will be useful in determining who should receive it. Such a treatment may not be far off: the Biogen drug candidate  aducanumab is  set for review by a US Food and Drug Administration panel later this week.</p><p>澳大利亚弗洛里神经科学研究所和心理健康研究所的科林·马斯特斯（Colin Masters）指出，基于症状的阿尔茨海默氏病诊断准确率仅为70％，该团队是该疾病中淀粉样斑块的首批研究者。玛斯特斯说，如果临床医生怀疑这种疾病，但血液检查结果呈阴性，“这将迫使临床医生更加努力寻找其他原因导致的痴呆症。”与试验开发者之一合作但与2N。他补充说，针对淀粉样蛋白的阿尔茨海默氏症药物一旦获得批准，该测试将有助于确定谁应该接受该药物。这种治疗可能还差得很远：Biogen候选药物aducanumab将于本周晚些时候由美国食品和药物管理局（FDA）小组审查。</p><p> The blood test is also likely to be a boon for clinical trials to develop other drugs, as it will make it easier to screen patients for recruitment, Fillit says. “Screening and enrollment represents up to fifty percent of the cost of clinical trials in Alzheimer’s disease, and one Phase 3 trial costs three to four hundred million dollars,” he says, calling the blood test a “huge advance in clinical trials.”</p><p> 菲利特说，验血也可能会为开发其他药物的临床试验带来福音，因为它将使筛查患者的招募更加容易。他说：“筛查和注册费用最多占阿尔茨海默氏病临床试验费用的50％，一项3期试验的费用为3亿到4亿美元，”他称血液检查是“临床试验的巨大进步。”</p><p>  Clarification (November 2): This article has been amended to state Masters’s working relationship with one of the test’s developers.</p><p>  说明性（11月2日）：本文经过修订，以说明Masters与该测试的一名开发人员的工作关系。 </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/美国/">#美国</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/阿尔茨海默氏症/">#阿尔茨海默氏症</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/blood/">#blood</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/患者/">#患者</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>